Skip to main content
. 2004 Jan 26;141(4):709–716. doi: 10.1038/sj.bjp.0705634

Table 1.

Systemic leukocyte counts

  MNL PMNL Total
Control 2.4±0.4 0.7±0.1 3.1±0.4
PBS+LPS/Gal 3.1±0.4 1.6±0.2 4.8±0.6
LFA-1−/−+LPS/Gal 4.5±1.5 1.7±0.3 6.2±1.6
Control ab+LPS/Gal 3.0±0.4 1.2±0.4 4.2±0.6
Anti-LFA-1 ab+LPS/Gal 4.6±1.0 1.0±0.2 5.6±1.2

Leukocytes were counted in a hematocytometer and defined as mononuclear (MNL) or polymorphonuclear (PMNL). Animals received a combination of LPS (10 μg) and D-galactosamine (Gal, 18 mg) in wild-type or LFA-1-deficient mice (−/−). Negative control animals received PBS (Control). Animals were pretreated with a monoclonal antibody against LFA-1 (M17/4.4.11.9, 100 μg per mouse) and a control antibody (9-A2, 100 μg per mouse) or PBS. Data represent means±s.e.m., and n=5–8.